DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Cipla Limited — Outcome of Board Meeting

NSE 1 hr ago·27 Oct 2026, 8:01 am

Cipla

Cipla Limited has informed the stock exchange about its financial results for the quarter and nine months ending September 30, 2026. The company submitted these documents to comply with regulatory disclosure norms.

This update is a routine procedural step for listed entities. For investors, it provides the first official data point on the company's performance during the current fiscal year. Reviewing these figures is essential to understand the company's operational health and financial trajectory.

Investors should focus on key metrics like revenue growth, profit margins, and the performance of key drug portfolios. These details will offer insights into the company's future direction and market standing.